Gene Therapy Could Make Cancer Care More Unequal - This is How | Front Line Genomics

Gene Therapy Could Make Cancer Care More Unequal - This is How | Front Line Genomics

Gene Therapy Could Make Cancer Care More Unequal – This is How

17 JAN 18

James Bell

Health provision disparity between regions is a perennial problem across the world. New therapies such as CAR-T cell immunotherapies  Kymriah and Yescarta,  which were approved last year in the USA, can be expensive and require highly specialised supervision.  Kymriah is $475,000 and Yescarta is $373,000 for a one-time treatment—but for now, you can get them only in certain urban areas. MIT Technology Review created an interactive map of the access points below: